Deadline: 13-Nov-2024

The competitive call for collaborator(s) seeks to identify investigators with innovative research proposals who are interested in partnering with Pfizer and potentially other likeminded investigators on co-developing research studies in migraine.

Proposals selected from this CFC(s) will work in collaboration with the Pfizer medical team to co-develop a research project and final study protocol. In all studies, the investigator will be the regulatory sponsor of the study.

Project Types and Area of Interest 

• Globally, there are more than one billion people living with migraine and it ranks among the top three most debilitating neurological diseases. While research into the ethology and treatment of migraine continues to advance, key knowledge gaps remain. The intent of this CFC is to identify investigators with innovative research ideas who want to partner and co-develop research studies with Pfizer, and potentially other investigators where multiple proposals share similar objectives and methodological approaches.
• In these instances, Pfizer along with the investigators, may pursue a single research study with multiple sites should all the parties agree. This CFC will be a twostep process. The first step will be for investigators to submit a Letter of Intent (LOI) providing a high-level synopsis of the proposed project. In the second step, LOIs will be selected for further development into a research collaboration with Pfizer.

Funding Information

• Study design for a single site, up to $500,000 USD

Duration

• 24- 36 months.

Eligibility Criteria

• Geographic Scope
  • Global
• Applicant Eligibility Criteria
  • The institution and Principal Investigator (PI) must be based in one of the eligible countries.
  • Only organizations are eligible to receive funds and in-kind support, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
  • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
  • The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
  • The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).

For more information, visit Pfizer.